A Novel Multi-strain Vaginal Synbiotic is Effective in Optimizing the Vaginal Microbiome: Results from a Randomized, Placebo-controlled Clinical Trial
Ravel, J.; Greenwood Jaswa, E.; Gottfried, S.; Greene, M.; Kellogg-Spadt, S.; Gevers, D.; Harper, D.
Show abstract
This research letter describes the results of a clinical trial of a novel vaginal synbiotic comprising three L. crispatus strains and a supportive nutrient complex. Results indicated that administration of the synbiotic led to an optimal vaginal microbiome dominated by L. crispatus (CST I) and additionally reduced the abundance of microbes associated with vaginal dysbiosis and the abundance of Candida, the most common source of vaginal yeast infections.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluation of the efficacy of Lactobacillus -containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: A pilot randomized controlled trial 94%
- The rodent vaginal microbiome across the estrous cycle and the effect of genital nerve electrical stimulation 91%
- Effects of a spore-forming probiotic blend on bowel habits and physical well-being in adults with functional constipation: a randomized, double-blind, placebo-controlled trial 91%
Similar papers in this journal
- Multi-strain fermented milk promotes gut microbiota recovery after Helicobacter pylori therapy: a randomised, controlled trial 92%
- Are probiotics and prebiotics safe for use during pregnancy and lactation? A systematic review and meta-analysis 92%
- Effect of a novel food rich in miraculin on the intestinal microbiome of malnourished patients with cancer and dysgeusia 91%
Similar papers in this journal
- Cervicovaginal immune mediators increase when young women begin to have sexual intercourse: a prospective study and meta-analysis 91%
- Fungal-bacteria interactions provide shelter for bacteria in Caesarean section scar diverticulum 89%
- The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19 88%
Similar papers in this journal
- Defining Vaginal Community Dynamics: daily microbiome transitions, the role of menstruation, bacteriophages and bacterial genes 94%
- Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip 94%
- Microbial function and genital inflammation in young South African women at high risk of HIV infection 93%
Similar papers in this journal
- Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection 90%
- Microbiota supplementation with Bifidobacterium and Lactobacillus modifies the preterm infant gut microbiota and metabolome 89%
- The clinical drug candidate ebselen attenuates inflammation and promotes microbiome recovery after antibiotic treatment for Clostridium difficile infection 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.